Johanna J. S. Finnemann

Johanna J. S. Finnemann

University position

PhD student
Supervised by Prof Paul Fletcher

Departments

Department of Psychiatry

Institutes

Behavioural and Clinical Neuroscience Institute and Brain Mapping Unit

Research Themes

Cognitive and Behavioural Neuroscience

Systems and Computational Neuroscience

Interests

My primary research interests concern sensorimotor integration and somatosensation which I investigate from a computational as well as experimental point of view. In particular I aim to understand how optimal control, predictive processes, motor learning and proprioceptive accuracy may differ in individuals with autism spectrum disorders and how these differences relate to the functional connectivity of the primary motor cortex, premotor cortex, SMA and cerebellum.

Outside of my PhD I also help out with research on the computational and neurobiological basis of visual hallucinations drawing from both psychophysics as well as computer vision paradigms.

In addition I'm involved with the TIME-A project, a randomised controlled trial on music therapy for children with autism: http://uni.no/en/uni-health/gamut/trial-of-improvisational-music-therapys-effectiveness-for-children-with-autism-time-a/

Research Focus

Keywords

None specified

Clinical conditions

Autism

Schizophrenia

Equipment

No equipment indicated

Collaborators

No collaborators listed

Associated News Items


Publications

2017

Bieleninik Ł, Geretsegger M, Mössler K, Assmus J, Thompson G, Gattino G, Elefant C, Gottfried T, Igliozzi R, Muratori F, Suvini F, Kim J, Crawford MJ, Odell-Miller H, Oldfield A, Casey O, Finnemann J, Carpente J, Park A-L, Grossi E, Gold C (2017), “Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial” JAMA 318(6), 525–535

2015

Teufel C, Subramaniam N, Dobler V, Perez J, Finnemann J, Mehta P, Goodyer I, Fletcher P (2015), “Shift toward prior knowledge confers a perceptual advantage in early psychosis and psychosis-prone healthy individuals.” Proceedings of the National Academy of Sciences 112(43), 13401–13406